>

CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Trend from 2010 to 2020

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 40px;;'>CVS</div>
CVS -- USA Stock  

Earning Report: 6th of May 2020  

CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA yearly trend continues to be relatively stable with very little volatility. Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to grow to about 14.8 B this year. During the period from 2010 to 2020, CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA destribution of quarterly values had r-value of  0.41 from its regression line and mean deviation of  2,111,074,380. CVS Health Interest Expense is relatively stable at the moment as compared to the last year. CVS Health reported last year Interest Expense of 3.04 Billion. This year Income Tax Expense is likely to grow to about 2.7 B, while Direct Expenses is likely to drop slightly above 135.2 B.
View Historical Trends In Earnings Before Interest Taxes and Depreciation Amortization EB IT DA For
Refresh
Check CVS Health financial statements over time to gain insight into the future company performance. Apply historical fundamental analysis to find patterns among financial statement drivers such as Direct Expenses of 135.2 B, Consolidated Income of 6 B or Cost of Revenue of 182.9 B, as well as many exotic indicators such as Interest Coverage of 4.05, Long Term Debt to Equity of 1.09 or Calculated Tax Rate of 33.27. This can be a perfect complement to check CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Continue to the analysis of CVS Health Correlation with competitors.

CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Marginal Breakdown

Showing smoothed Earnings Before Interest Taxes and Depreciation Amortization EBITDA of CVS Health Corporation with missing and latest data points interpolated. EBITDA is a non-GAAP accounting metric that is widely used when assessing the performance of companies; calculated by adding [DepAmor] back to Earning Before Interest and Taxes EBIT.
View

14.83 B

          10 Years Trend
Increasing
Slightly volatile
 Earnings Before Interest Taxes and Depreciation Amortization EBITDA 
    
  Timeline 

CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Regression Statistics

Arithmetic Mean 9,850,181,818
Geometric Mean 9,397,025,038
Coefficient Of Variation 29.05
Mean Deviation 2,111,074,380
Median 9,899,000,000
Standard Deviation 2,861,220,398
Range 10,803,000,000
R-Value 0.41
R-Squared 0.17
Significance 0.21
Slope 352,963,636

CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Over Time

2018  4,027,000,000 
2019  12,035,000,000 
2020  14,830,000,000 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

CVS Health Fundamental Drivers

CVS Health Corporation Fundamental Market Drivers

Short Percent Of Float1.48%
Forward Price Earnings7.94
Shares Short Prior Month20.24M
Average Daily Volume Last 10 Day12.14M
Average Daily Volume In Three Month11.08M
Date Short Interest31st of May 2019
Fifty Day Average60.61
Two Hundred Day Average67.87

CVS Health Upcoming Events

CVS Health Upcoming Company Events

Upcoming Quarterly Earning Report6th of May 2020
Next Earnings Report5th of August 2020
Next Fiscal Quarter End31st of March 2020
Next Fiscal Year End10th of February 2021
Last Quarter Report Date31st of December 2019
Last Earning Anouncement Date31st of March 2019
Continue to the analysis of CVS Health Correlation with competitors. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page